
![]() |
|||||||||||||
WJPR Citation Report
|
| All | Since 2021 | |
| Citation | 9186 | 4781 |
| h-index | 32 | 25 |
| i10-index | 256 | 108 |
A CLINICAL STUDY TO EVALUATE THE EFFECT OF SHIGRUADI ASCHYOTAN (EYE DROPS) IN THE MANAGEMENT OF KAPHAJA ABHISHYANDA W.S.R. TO SEASONAL ALLERGIC CONJUNCTIVITIS
Dr. Shiwali Verma*, Prof. (Dr.) Sukhdev Singh, Prof. (Dr.) Vijayant Bhardwaj, Dr. Hardev Thakur, Dr. Pankaj
Abstract Background: Seasonal allergic conjunctivitis (SAC) presents predominantly with ocular itching, watering, redness and burning. The clinical features described for Kaphaja Abhishyanda in Ayurveda show substantial symptom-level correspondence with SAC. Aschyotana is described as an important Kriyakalpa for ocular disorders. The present study evaluated Shigruadi Aschyotan, a topical Ayurvedic eye-drop formulation, and compared its clinical outcomes with a standard comparator eye-drop combination. Methods: This simple randomized comparative clinical study was conducted in the P.G. Department of Shalakya Tantra, R.G.G.P.G. Ayurvedic College & Hospital, Paprola. Forty patients aged 10–70 years meeting the study criteria were enrolled and allocated into two groups of 20 each. Group I received Shigruadi Aschyotan and Group II received eye drops containing phenylephrine 0.12%, naphazoline hydrochloride 0.05%, menthol 0.005% and camphor 0.01%. Treatment was for 7 days with assessments on day 3, day 7 and follow-up after completion. Thirty-two patients completed treatment (16 in each group). Subjective and objective parameters were scored and analysed using mean, SD, SE and paired Student's t-test. Results: In Group I, significant or highly significant improvement was documented for itching (65.21%), lacrimation (45.46%), discharge (50%), heaviness (57.13%), photophobia (53.85%), burning sensation (61.90%), redness/congestion (48.49%) and conjunctival hyperemia (60%); upper tarsal papillae showed 40% relief and was not statistically significant. Between-group comparison was statistically significant for itching, photophobia and burning sensation, while the remaining parameters did not show a statistically significant difference. Overall, 12.5% of Group I patients were markedly improved, 50% moderately improved and 37.5% mildly improved. Conclusion: Within the limits of this small, short-duration study, Shigruadi Aschyotan was associated with improvement in the evaluated clinical features of Kaphaja Abhishyanda/SAC, with no adverse effects reported in the dissertation. Larger studies with longer follow-up are required to establish the magnitude and durability of the observed effects. Keywords: Kaphaja Abhishyanda; Seasonal Allergic Conjunctivitis; Shigruadi Aschyotan; Aschyotana; Kriyakalpa; Ayurveda. [Full Text Article] [Download Certificate] |
